A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of three anti-HIV drug
combinations. The three combinations are: (1) efavirenz (DMP 266) plus indinavir; (2) DMP 266
plus zidovudine (ZDV) plus lamivudine (3TC); and (3) indinavir plus ZDV plus 3TC. This study
also examines the resistance HIV may have to these drugs and if these drugs are effective
over a long period of time.